|
Mr. Walsh became our Executive Vice President and Chief Commercial Officer in March 2008. Prior to Cypress Mr. Walsh founded Proprius Pharmaceuticals Inc. in 2005 and was its President and CEO from its founding until we acquired Proprius in March 2008. Prior to establishing Proprius Mr. Walsh was a founder and Executive Chairman at Prometheus Laboratories Inc. a specialty pharmaceutical company from 1995 to 2005. Prior to founding Prometheus Laboratories Inc. Mr. Walsh was with Quidel Corporation in various senior executive roles including Director of Worldwide Marketing and Business Development and Director of European Operations. Prior to Quidel he was Manager of Therapeutic Operations at La Jolla Pharmaceutical Company. Mr. Walsh serves on the Board of Directors of Kanisa Pharmaceuticals Inc. and as Chairman of the Board of Oculir Inc. Mr. Walsh has a Bachelor of Science degree from the University of Notre Dame and an M.B.A. from Pepperdine University. | 